SMS Lifesciences India Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SMS Lifesciences India Limited generated cash of $243,055,000, which is more than the previous year. Cash used in financing activities reached the amount of -$65,635,000 last year. Net change in cash is therefore -$7,083,000.
Cash Flow
| 2016 | 0 | 0 | 0 |
|---|---|---|---|
| 2018 | 80.00M | -68.35M | -8.06M |
| 2020 | 145.46M | -270.19M | 124.45M |
| 2021 | 351.69M | -262.34M | -25.46M |
| 2023 | 1.46K | -3.12K | 1.68K |
| 2024 | 243.05M | -184.50M | -65.63M |
SMSLIFE.NS Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 12.77M | 98 | 21.47M | 21.74M | 773K | 0 |
Operating activities | ||||||
Net income | 90.92M | 1.42K | 195.67M | 146.68M | 63.96M | -19K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 149.37M | 1.07K | 78.61M | 78.61M | 57.03M | 0 |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -53.37M | -127.42M | -120.58M | 203.48M | 121.79M | 0 |
Inventories | 50.24M | -28 | 26.66M | 169.49M | -55.21M | 0 |
Accounts payable | -2.17M | -4 | 170.10M | -501.16M | -110.10M | 0 |
Cash generated by operating activities | 243.05M | 1.46K | 351.69M | 145.46M | 80.00M | 0 |
Investing activities | ||||||
Purchases Of Investments | 0 | -11 | -20.19M | -38M | -49.62M | 0 |
Investments In Property Plant And Equipment | -208.67M | -4.85K | -355.56M | -233.53M | -34.97M | 0 |
Acquisitions Net | 0 | 594 | 4.74M | 1.32M | 0 | 0 |
Cash generated by investing activities | -184.50M | -3.12K | -262.34M | -270.19M | -68.35M | 0 |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -4.53M | -4.53M | 0 | -5.46M | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 1.83M | 178.91M | -62.66M | 78.90M | -6.97M | 0 |
Cash used in financing activities | -65.63M | 1.68K | -25.46M | 124.45M | -8.06M | 0 |
Net Change In Cash | -7.08M | 29 | 63.88M | -270K | 3.58M | 0 |
Cash at end of period | 5.69M | 127 | 85.36M | 21.47M | 4.35M | 0 |
| Data source | Data source | Data source | Data source | Data source | Data source |